0 évaluation0% ont trouvé ce document utile (0 vote)
16 vues19 pages
This document discusses genetic disorders and techniques for treating them, including gene replacement and supplementation. It provides examples of how these techniques work, such as replacing the defective cystic fibrosis gene or supplementing the ADA gene in SCID. However, it also notes several disadvantages and ethical concerns with gene therapy, such as its short-term effectiveness, deciding what is "normal," unpredicted long-term effects, and related issues around eugenics.
This document discusses genetic disorders and techniques for treating them, including gene replacement and supplementation. It provides examples of how these techniques work, such as replacing the defective cystic fibrosis gene or supplementing the ADA gene in SCID. However, it also notes several disadvantages and ethical concerns with gene therapy, such as its short-term effectiveness, deciding what is "normal," unpredicted long-term effects, and related issues around eugenics.
Droits d'auteur :
Attribution Non-Commercial (BY-NC)
Formats disponibles
Téléchargez comme PPT, PDF, TXT ou lisez en ligne sur Scribd
This document discusses genetic disorders and techniques for treating them, including gene replacement and supplementation. It provides examples of how these techniques work, such as replacing the defective cystic fibrosis gene or supplementing the ADA gene in SCID. However, it also notes several disadvantages and ethical concerns with gene therapy, such as its short-term effectiveness, deciding what is "normal," unpredicted long-term effects, and related issues around eugenics.
Droits d'auteur :
Attribution Non-Commercial (BY-NC)
Formats disponibles
Téléchargez comme PPT, PDF, TXT ou lisez en ligne sur Scribd
Treatment for genetic disorders using techniques that replace or
supplement the defective gene.
But they are usually recessive, and therefore do not cause problems. One dominant, normal allele can control the production of a normal protein, so the person is usually unaware that they have a defective gene. The allele frequency for the defective allele is 0.025 (in one person in 40) Therefore using Hardy-Weinberg, q2 = 0.025 x 0.025 = 0.000625 In a population of 60 000 000 (roughly UK), this means that 37,500 will suffer from this condition. It is one of the commonest genetic disorders in European/N. American populations • Cf is caused by a deletion mutation of three bases from the normal gene. • The protein produced is still partly functional. Why? • The protein forms a trans-membrane channel for chloride ions to move out of epithelial cells. • Water follows the ions by osmosis. Thus the epithelium is kept moist. The faulty gene produces a protein that does not allow the chloride ions to move through. The epithelium is therefore too dry. Mucus produced from goblet cells is viscous and sticky. • Respiratory tract infections as cilia can’t move the cf mucus which has trapped pathogenic organisms entering the lungs. • Digestive difficulties as cf mucus blocks ducts such as pancreatic duct, through which enzymes pass to mix with food. (These blockages form cysts, hence the name of the condition.) • Cf mucus blocks ducts in testes and oviducts, leading to low fertility. Physiotherapy physically moves the mucus out of the respiratory tract. Enzymes are eaten with food to help digestion. Antibiotics taken daily keep infections under control. There are two techniques that can help cystic fibrosis and other genetic disorders: Gene replacement: the defective gene is replaced with a healthy gene. Gene supplementation: one or more copies of the healthy gene are added to the cell alongside the defective gene. This works because the defective gene is recessive, so the healthy gene is expressed. This replaces or supplements the gene in the zygote. All cells that arise from the zygote, including the gametes, therefore have a copy of the healthy gene and the child should be born completely free of the condition. Further, the next generation should also be unaffected by the disease. Such a radical treatment has far-reaching ethical and moral issues. This process is, at present, illegal. This targets the affected tissue, after birth. Only some of the affected cells are likely to take up the healthy genes. All cells have a finite life. This means that the treatment will need to be repeated when the treated cells come to the end of their life and are replaced by cells that carry the defective allele. The gametes will still carry the defective allele. A large number of the genes (i.e. pieces of DNA) need to be produced/cloned. This will be by in-vitro cloning (Polymerase Chain Reaction). The gene will need to be carried into the tissues by a vector. This could be a plasmid, a modified virus or a liposome (sphere of lipid ). Viruses inject their DNA into host cells. Therefore they should be ideal as vectors. The virus must be made harmless by blocking a gene involved in its replication. The modified virus is then grown in cells along with a plasmid containing the healthy gene. The virus takes up the plasmid plus the healthy gene. The cf sufferer is given the virus, often by inhalation of a nasal spray. The virus infects the cells and in doing so injects the gene. Lipids pass fairly readily through the phospholipid bilayer of the cell membrane, so can introduce the new gene into the cell. The gene is isolated from healthy human DNA and inserted into a plasmid vector. The plasmids are put into bacterial cells. As the bacteria multiply the plasmid plus gene is cloned (in- vivo cloning). The plasmids are extracted from the bacteria and enclosed in lipid molecules to form a liposome. The patient is given the liposomes as a nasal spray. People with this condition are unable to produce antibodies and have no cell-mediated response. The defect is in a gene that codes for an enzyme, ADA. Copies of a normal ADA gene are isolated and cloned. The gene is inserted into a virus. The virus is multiplied in a laboratory by growing it inside host cells. The viruses are mixed with the patients T-cells. The T-cells are then replaced back into the patient. Rarely, deaths have occurred as a result of the virus. Immunity can develop to the virus, so it is destroyed before it can introduce the gene. Liposomes are quite large, bigger than the narrowest bronchioles, so some parts of the lungs remain untreated. Even when the gene enters the cell, it is often not expressed, for unknown reasons. ADVANTAGES DISADVANTAGES
Can prolong life for affected Effectiveness of treatment often
individuals very short-lived Treatment needs to be frequently Effective against some repeated (somatic therapy) cancers Some tissues are much less Improves quality of life for accessible than lung or blood so affected individuals administration more difficult Allele in the wrong place could Could (germ line therapy) cause cancer reduce incidence of disease in Gene could be over-expressed the population producing too much protein Not likely to be useful if several genes affected, e.g. in cancers Who decides what is “normal”? Clear in some examples e.g. cystic fibrosis, but not in many other genetic conditions. Must we cure genetic “faults” or accept them as part of natural biological variation? Some apparently harmful conditions bring unusual benefits: Down syndrome people hardly every suffer from cancer because they have multiple copies of a gene that produces an enzyme that helps eliminate mutations. Gene therapy and research are very expensive: should money be spend on proven treatments where success is more likely? The long-term effects of introducing genes into a population cannot be predicted. Could it be the forerunner of a system of eugenics?